Autopsy report · NCT00320918

Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“This was a Chart Review only and was entered in the system in error.”

The sponsor’s own words in the registry.

Life of this trial

Registered 5 months after it had already started.
Ran for about 11 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: University of New Mexico
Sponsor type: University, hospital or other
Conditions: Cholangiocarcinoma
Participants: 10
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.